Skip to Main Content

Author Details

Matthew J Meyer
University of Virginia School of Medicine
2009
41
20
Sarah J Ratcliffe (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36863346Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy.Cell Chem Biol2023
37609369Sterile surgical supply waste identification using asynchronous analysis: Pediatric surgery QI pilot.Surg Open Sci2023
36656845Clinical implications of preoperative echocardiographic findings on cardiovascular outcomes following vascular surgery: An observational trial.PLoS One2023
35093247Surgeons' perspectives on operating room waste: Multicenter survey.Surgery2022
35990699CRISPR screening identifies T cell-intrinsic regulators of CD3-bispecific antibody responses.Front Immunol2022
33046519Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling.Clin Cancer Res2021
34127600In Response.Anesth Analg2021
31923000Variation in Patient-Reported Advance Care Preferences in the Preoperative Setting.Anesth Analg2021
33449565In Response.Anesth Analg2021
32925355Desflurane Should Des-appear: Global and Financial Rationale.Anesth Analg2020
31668357Concordance in advance care preferences among high-risk surgical patients and surrogate health care decision makers in the perioperative setting.Surgery2020
32910655Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer.J Med Chem2020
32847974Development of Anti-CD32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell Malignancies.Mol Cancer Ther2020
31451483Cyclophosphamide Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression.Cancer Immunol Res2019
31439712Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers.Mol Cancer Ther2019
31527224Distinct Transcriptional Programming Drive Response to MAPK Inhibition in <i>BRAF</i> <sup>V600</sup>-Mutant Melanoma Patient-Derived Xenografts.Mol Cancer Ther2019
28786842Reduction in Operating Room Plasma Waste After Evidence-Based Quality Improvement Initiative.Anesth Analg2018
28067700Fresh-Frozen Plasma: Ordering Patterns and Utilization in the Operating Rooms of a Tertiary Referral Hospital.Anesth Analg2017
28526733Discovery and Optimization of HKT288, a Cadherin-6-Targeting ADC for the Treatment of Ovarian and Renal Cancers.Cancer Discov2017
28632616Should Neuromuscular Blocking Agents Always Be Reversed?Anesthesiology2017
26991623The Mandate to Measure Patient Experience: How Can Patients "Value" Anesthesia Care?Anesth Analg2016
27707496Early, goal-directed mobilisation in the surgical intensive care unit: a randomised controlled trial.Lancet2016
27362227Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases.Nature2016
27347692Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor.J Med Chem2016
27187609Toward the Validation of Maternal Embryonic Leucine Zipper Kinase: Discovery, Optimization of Highly Potent and Selective Inhibitors, and Preliminary Biology Insight.J Med Chem2016
27404221Effects of Depth of Propofol and Sevoflurane Anesthesia on Upper Airway Collapsibility, Respiratory Genioglossus Activation, and Breathing in Healthy Volunteers.Anesthesiology2016
26510199In Reply.Anesthesiology2015
26490646Inhibition of Casein Kinase 1 Alpha Prevents Acquired Drug Resistance to Erlotinib in EGFR-Mutant Non-Small Cell Lung Cancer.Cancer Res2015
24520176Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers.Proc Natl Acad Sci U S A2014
25225821Effects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes: a prospective study.Anesthesiology2014
25275368Anesthesia and increased hypercarbic drive impair the coordination between breathing and swallowing.Anesthesiology2014
23512446Neostigmine reversal doesn't improve postoperative respiratory safety.BMJ2013
23845791Oral midodrine treatment accelerates the liberation of intensive care unit patients from intravenous vasopressor infusions.J Crit Care2013
23959756Surgical Intensive Care Unit Optimal Mobilisation Score (SOMS) trial: a protocol for an international, multicentre, randomised controlled trial focused on goal-directed early mobilisation of surgical ICU patients.BMJ Open2013
23429163Postoperative respiratory muscle dysfunction: pathophysiology and preventive strategies.Anesthesiology2013
23584384Muscle weakness predicts pharyngeal dysfunction and symptomatic aspiration in long-term ventilated patients.Anesthesiology2013
20578247Local regulation of human breast xenograft models.J Cell Physiol2010
20492690The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo.BMC Med2010
20549704Cripto-1 is a cell surface marker for a tumorigenic, undifferentiated subpopulation in human embryonal carcinoma cells.Stem Cells2010
20484027CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer.Cancer Res2010
19906290Dynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell lines.Breast Cancer Res2009
  • 1 - 41 of 41

Recommended Authors

Mayo Clinic
Career Start Year 2017
Number of shared co-authors 0
Weill Cornell Medical College
Career Start Year 2017
Number of shared co-authors 0
Imperial College London
Career Start Year 2016
Number of shared co-authors 0
Duke University Medical Center
Career Start Year 2015
Number of shared co-authors 0
University of Florida Health
Career Start Year 2015
Number of shared co-authors 0
University of Virginia Health System
Career Start Year 2014
Number of shared co-authors 1
University of California Los Angeles
Career Start Year 2013
Number of shared co-authors 0
Beth Israel Deaconess Medical Center
Career Start Year 2011
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 2010
Number of shared co-authors 0
Vanderbilt University
Career Start Year 2009
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2009
Number of shared co-authors 0
Penn State Hershey Medical Center
Career Start Year 2008
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2007
Number of shared co-authors 1
University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 2006
Number of shared co-authors 0
Cork University Hospital
Career Start Year 2006
Number of shared co-authors 1
Boston Children's Hospital
Career Start Year 2005
Number of shared co-authors 0
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year 2001
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 1
Goethe University, University Hospital Frankfurt
Career Start Year 1997
Number of shared co-authors 0
University of California San Diego
Career Start Year 1997
Number of shared co-authors 1
Beth Israel Deaconess Medical Center
Career Start Year 1992
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 1992
Number of shared co-authors 0
University of Florida College of Medicine
Career Start Year 1991
Number of shared co-authors 0
12284University of Nebraska Medical Center
Career Start Year 1991
Number of shared co-authors 0
University of South Florida Morsani College of Medicine
Career Start Year 1989
Number of shared co-authors 0
University of Oxford
Career Start Year 1987
Number of shared co-authors 0
Duke Cancer Center Cary
Career Start Year 1979
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 1943
Number of shared co-authors 0

Collaborators

Co-authored papers 4
National Cancer Institute, National Institutes of Health
Co-authored papers 4
Co-authored papers 2
University of California San Diego Health
Co-authored papers 2
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Novartis Institutes for BioMedical Research
Co-authored papers 2
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
University of Virginia
Co-authored papers 1
University of Virginia School of Medicine
Co-authored papers 1
University of Virginia School of Medicine
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Spaulding Rehabilitation Hospital, Harvard Medical School
Co-authored papers 1
Instituto Do Cancer Do Estado de Sao Paulo
Co-authored papers 1
Newton Wellesley Hospital
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
University of Virginia School of Medicine
Co-authored papers 1
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 1
Sir Charles Gairdner Hospital
Co-authored papers 1
Albany Medical College in New York, Union University in Schenectady.
Co-authored papers 1
Mayo Clinic
Co-authored papers 1
University of Virginia
Co-authored papers 1
Novartis Institutes for Biomedical Research
Co-authored papers 1
Co-authored papers 1
University of Virginia
Co-authored papers 1